MAPK3 and breast cancer: Since our findings (Figure 3) and others had shown that doxycycline inhibited ERK1/2 activation, we further investigated the role of the ERK1/2-dependent signal transduction pathway in doxycycline-induced biological activities in breast cancer MDA-MB-231 cells.